Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daisy Manish Shah"'
Autor:
Satyawan Jadhav, Sanjay Deshmukh, Siddharth Mhatre, Abhay Kulkarni, Shital Tondlekar, Samitabh Chakraborti, Nagarajan Muthukaman, Macchindra Tambe, Dnyandeo Pisal, Vikram Mansingh Bhosale, Neelam Sarode, Daisy Manish Shah, Mahamad Yunnus A. Mahat, Girish S. Gudi, Neelima Khairatkar-Joshi, Laxmikant Atmaram Gharat
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:3766-3773
Endogenous nitrosothiols (SNOs) including S-nitrosoglutathione (GSNO) serve as reservoir for bioavailable nitric oxide (NO) and mediate NO-based signaling, inflammatory status and smooth muscle function in the lung. GSNOR inhibition increases pulmona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69f3548323ec6b3cb510c32ec44b9f3
https://doi.org/10.1016/j.bmcl.2018.10.012
https://doi.org/10.1016/j.bmcl.2018.10.012
Autor:
Rambabu Pattem, Rajni R. Thakur, Srinivas Kummari, Neelima Khairatkar-Joshi, Ratika S. Sapalya, Satyawan Jadhav, Abraham Thomas, Praveen Kumar Gupta, Vijay Eknath Rathi, Ajit Shankar Mindhe, V. S. Prasadarao Lingam, Srinivas Gullapalli, Yogesh B. Shingote, Malini Bajpai, Girish S. Gudi, Daisy Manish Shah, Dnyaneshwar Harishchandra Dahale
Publikováno v:
Journal of medicinal chemistry. 58(20)
We report the design and synthesis of novel 5,6-diarylated pyridin-2(1H)-one derivatives as pharmacophoric PDE10A inhibitors. This highly potent molecular scaffold was developed from an inactive diarylpyridine-2-amine derivative 3b by extensive and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0e8e56e67ac2b24daa73ede3627f758
https://pubmed.ncbi.nlm.nih.gov/26421921
https://pubmed.ncbi.nlm.nih.gov/26421921
Autor:
Sachin Sundarlal Chaudhari, Abraham Thomas, Daisy Manish Shah, Satyawan Jadhav, Malini Bajpai, Srinivasa Honnegowda, Neelima Khairatkar-Joshi, Sanjib Das, Abhay Kulkarni, Girish S. Gudi, Indrani Sarkar
Publikováno v:
5.1 Airway Pharmacology and Treatment.
Background: Antibody mediated IL-17 blockade is remarkably successful in autoimmune disease treatment. Recent studies implicate IL-17 in airway diseases. Increased IL-17 immuno-reactivity and Th17 cells in lung tissue and IL-17 level in bronchoalveol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e818c1c6a349e09a78bef81fce255b97
https://doi.org/10.1183/13993003.congress-2015.pa4367
https://doi.org/10.1183/13993003.congress-2015.pa4367
Autor:
Abraham Thomas, Daisy Manish Shah, V. S. Prasadarao Lingam, Neelima Khairatkar-Joshi, Indranil Mukhopadhyay
Publikováno v:
Pharmaceutical patent analyst. 4(3)
The transient receptor potential canonical (TRPC) channels have gained interest as potential therapeutic targets for respiratory diseases, neurological disorders, cardiovascular disorders, pain, cancer and several other pathological conditions. The T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::025e9f44592b85ef5eb66237b256752a
https://pubmed.ncbi.nlm.nih.gov/26030081
https://pubmed.ncbi.nlm.nih.gov/26030081